Epidermoid carcinoma of the lip: An immunohistochemical study;Estudio inmunohistoquímico del carcinoma epidermoide de labio

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 10, Issue 5, 2005, Pages 454-461

  García Montesinos Perea, Belén ^a,c   Val Bernai, José Fernando ^a,b   Saiz Bustillo, Ramón ^a,b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c C/ Castelar n 5 2 derecha ^*  (Spain)

Author keywords

bcl 2; c erb B2; Cancer of the lip; CD44; Epidermoid carcinoma; Immunohistochemistry; Ki67; p53

Indexed keywords

CD44V6 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; CELL PROLIFERATION; CLINICAL PRACTICE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIP CARCINOMA; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; COST-BENEFIT ANALYSIS; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIP NEOPLASMS; NEOPLASM PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 27944482206     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Garcia R, Coltrera MB, Gown AM. Analysis of proliferative grade with anti PCNA7 cyclin monoclonal antibodies in fixed embedded tissues. Am J Pathol 1989;134:733-9.
2. Harris C, Hollstein M. Clinical implications of the p53 tumor supressor gene. N Eng J Med 1993;329:1318-27.
3. Harris C. Chemical and physical carcinogenesis:advances and perspectives for the 1990's. Cancer Res 1991;51:5023-44.
4. Werness B, Levine A, Howley P. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Sciencie 1990;248:76-9.
5. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53 associates protein in human sarcoma. Nature 1992;358:80-3.
6. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C et al. Inmunobiochemical and molecular biologic characterization of cell proliferation-associated nuclear antigen. That is defined by monoclonal antibody Ki67. Am J Pathol 1991;138:867-73.
7. Hudson D, Speight P, Watt F. Altered expression of CD44 isoforms in squamous cell carcinomas and cell lines derived from these. Int J Cancer 1996;66:457-63.
8. Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, Zoller J et al. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinoma of the head and neck. J Pathol 1996;179:66-73.
9. Soukka T, Salmi M, Joensuu H, Hakkinen L, Sointu P, Koulu L et al. Regulation of CD44 var v6 containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res 1997;57:2281-9.
10. Craven JM, Pavelic ZP, Stambrook PJ, Pavelic L, Gapany M, Kelley DJ et al. Expression of c-erb-2 gene in human head and neck carcinoma. Anticancer Res 1992;12:2273-6.
11. Field J, Spandidos DA, Yiagnisis M, Gosney JR, Papadimitriou K, Stell PM. C-erb-b2 expression in squamous cell carcinoma of the head and neck. Anticancer Res 1992;12:613-20.
12. Takes RP, Baatenburg de Joung RJ, Schuuring E, Hermans J, Vis AA, Litvinov SV et al. Marker for assesment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1997;123:412-9.
13. Weinstein G, Nuamah I, Tucker J, Montone K. Evaluation of HER-2/neu (cerb-B2) oncogene expression in whole organ sections of supraglottic squamous cell carcinoma. Ann Otol Rhinol Laryngol 1996;105:275-9.
14. Hynes N. Amplification and overexpression of the cerb-b2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for a cancer therapy. Semin Cancer Biol 1993;4:19-26.
15. Mansoor A, Mc Kee PH, Simpson JA, McGuire B, Hobbs C. Prognostic significance of ki67 and p53 inmunorreactivity in cutaneous squamous cell carcinomas. Am J Dermatopathol 1996;18:351-7.
16. Santer R, Ridge J. p53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue base. Am J Surg 1992;164:651-3.
17. Berner A, Holm R, Naess A , Hjortdal O. p53 protein expression in squamocellular carcinomas of the lip. Anticancer Res 1993;13:2421-4.
18. Fabbrocini G, Russo N, Pagliuca MC, Delfino M, Staibano S, Molea G et al. p53, cyclin-D1, PCNA, AgNOR expression in squamous cell cancer of the lip: a multicenter study. Photodermatol Photoimmunol Photomed 2000;16:172-7.
19. Crosthwaite N, Teale D, Franklin C, Foster GA, Stringer BM. p53 protein expression in malignant, pre-malignant and non-malignant lesions of the lip. J Clin Pathol 1996;49:648-53.
20. Li Ma MD, Adam Ronai PD. Expression of p53 and Bcl-2 in squamous cell carcinoma of the Head and Neck: An inmunohistochemical study. Appl Inmunohistochemi 1998;6:77-83.
21. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA et al. Tumor supressor P53 is a regulator of bcl-2 and box gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805.
22. Tubiana M, Conroli A. Proliferation kinetics in human solid tumors relation to probability of metastatic dissemination and long term survival. Radiother Oncol 1989;15:1-18.
23. Lorz M, Meyer-Breiting E. Determination of cell proliferation using monoclonal antibodies studies of 21 squamous cell carcinoma of the head and neck area. Laryngol Rhinol Otol 1988;67:539-42.
24. Ogawa Y, Inomata T. Changes in Ki67 labeling rates of head and neck squamous cell carcinomas during preoperative radiation therapy. Oncology 1992;49:450-3.
25. Raybaud-Diogene H, Fortin A, Morency R, Roy J, Monteil RA, Tetu B. Markers of radioresistence in squamous cell carcinomas of the head and neck: A clinicopathologic an inmunohistochemical study. J Clin Oncology 1997;15:1030-8.
26. Bahar R, Kunishi M, Kayada Y, Yoshiga K. CD44varV6 expression as a progression marker in benign, premalignant and malignant oral epithelial tissues. Int J Oral Maxillofac 1997;26:443-6.
27. Kunishi M, Kayada Y, Yoshiga K. Down regulated expression of CD44varV6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis. Int J Oral Maxillofac 1997;26:280-3.
28. Piffko J, Bankfalvi A, Klauke K, Dreier R, Joos U, Bocker W et al. Unaltered strong inmunohistochemical expression of CD44v6 and CD44v5 isoforms during development and progression of oral squamous cell carcinomas. J Oral Pathol Med 1996;25:502-6.